期刊文献+

子宫切除术围术期抗生素应用的探讨

Prophylactic Application of Antibiotics during Perioperative Period in Patients Undergoing Hysterectomy
下载PDF
导出
摘要 目的探讨子宫切除术围术期预防性应用抗生素不同用药方法预防术后感染的效果。方法将160例因各种子宫良性病变而行经腹子宫全切除术患者按用药方法分为4组,每组40例。A组:术前24 h初次给药,术后用药3 d;B组:术前30 min初次给药,术后用药3 d;C组:术后用药3 d;D组:术后用药5 d。药物均选用甲硝唑与头孢噻肟钠。结果术后最高体温B组低于A、C、D组(P<0.05),术后退热时间B组较A、C、D组短(P<0.05),术后病率B组较A、C、D组显著降低(P<0.05),术后感染(均为腹部切口感染)率,B组均低于A、C、D组(P<0.05)。A、C、D组间各指标比较差异均无统计学意义(均P>0.05)。术后不良反应各组间比较差异无统计学意义(均P>0.05)。结论子宫切除术前30 min使用抗生素较术前24 h使用抗生素更有效、合理,术后抗生素应用时间多于3 d与3 d以内相比不能降低感染率。 Objective To investigate the efficacy of different administration schedule of antibiotics during perioperative period in the prevention of postoperative infection in patients undergoing hysterectomy.Methods A total of 160 patients who underwent abdominal total hysterectomy for benign uterine disease were divided into four groups.The metronidazole and cefotaxime sodium were given 24 hours before operation and 3 days after operation in group A,30 minutes before operation and 3 days after operation in group B,3 days after operation in group C,and 5 days after operation in group D.Results Compared with group B,the highest temperature,antifebrile time,morbidity rates and incision infection rates significantly increased after operation in group A,C and D(P0.05),but there were no significant differences among the three groups(P0.05).In addition,no obvious differences in postope-rative adverse events were found among the four groups(P0.05).Conclusion The usage of antibiotics at 30 minutes before hysterectomy is more effective and rational than that at 24 hours before hysterectomy.And antibiotics used for more than 3 days can not decrease infection rates compared with those used for less than 3 days.
出处 《实用临床医学(江西)》 CAS 2012年第11期61-62,69,共3页 Practical Clinical Medicine
关键词 子宫切除术 围术期 抗生素 hysterectomy perioperative period antibiotics
  • 相关文献

参考文献4

二级参考文献20

  • 1王世阆 杨延林 等.腹式子宫全切除术预防性应用抗生素的临床观察[J].中华妇产科杂志,1987,22:214-214.
  • 2卞度宏 徐小蓉 等.经腹全子宫切除术时预防性应用抗生素的探讨[J].中华妇产科杂志,1987,22(3):138-138.
  • 3[1]Burke JP. Infection control-a problem for patient safety. N Engl J Med,2003,348:651-656.
  • 4[2]Kirkland KB, Briggs JP, Trivette SL, et al. The impact of surgical site infections in the 1990s: attributable mortality,excess length of hospitalization, and extra costs. Infect control Hosp Epidemiol,1999,20:725-730.
  • 5[3]Hollenbeak CS, Murfhy D, Dunagan WC, et al. Nonrandom selection and the attributable cost of surgical-site infections. Infect contral Hosp Epidemiol,2002,23:174-176.
  • 6[4]Perencevich EN, Sands KE, Cosgrove SE, et al. Health and economic impact of surgical site infections diagnoses after hospital discharge. Emerg Infect Dis,2003,9:196-203.
  • 7[5]Bratzler DW, Houck PM. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis, 2004,38:1706-1715.
  • 8[6]Fernandez H. Antibiotic prophylaxis in cesarean section and voluntary termination in pregnancy. Ann Fr Anesth Reanim, 1994,13:S128-134.
  • 9[8]Burke JF. The effective period of preventive antibiotic action in experimental incisions and dermal lesions. Surgery,1961,50:161-168.
  • 10[9]Stone HH, Hooper CA, Kolb LD, et al. Antibiotic prophylaxis in gastric, biliary and colonic surgery. Ann Surgery, 1976,184:443-452.

共引文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部